U.S. Markets open in 3 hrs 58 mins
S&P Futures
2,447.50
-5.25 (-0.21%)Dow Futures
21,854.00
-32.00 (-0.15%)
| Previous Close | 1.34 |
| Open | 1.27 |
| Bid | 0.00 x 0 |
| Ask | 1.50 x 2500 |
| Day's Range | 1.27 - 1.30 |
| 52 Week Range | 1.11 - 3.09 |
| Volume | 24,534 |
| Avg. Volume | 26,250 |
| Market Cap | 18.86M |
| Beta | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.89 |
- Marketwired•6 days ago
Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM
Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of CaPre for the treatment of severe hypertriglyceridemia, announced that the following individuals ...
- Associated Press•8 days ago
Acasti reports 1Q loss
The Laval, Quebec-based company said it had a loss of 14 cents per share. In the final minutes of trading on Monday, the company's shares hit $1.29. A year ago, they were trading at $1.42. _____ This story ...
- Marketwired•8 days ago
Acasti Pharma Reports First Quarter FY 2018 Financial Results
Acasti Pharma Inc. , a biopharmaceutical innovator focused on the research, development and commercialization of CaPre for the treatment of severe hypertriglyceridemia, today announced its operating and ...
